Form 4: Agilon Health Director Mansukani Reports Acquisition of 32,119 Shares

Director Sharad Mansukani reports acquiring 32,119 shares of Agilon Health common stock on May 29, 2024, and holding 1,274,033 shares following the transaction.

Summary

• On May 29, 2024, Sharad Mansukani, a director of Agilon Health, Inc. acquired 32,119 shares of common stock.
• The acquisition was in the form of restricted stock units that vest fully on May 29, 2025, contingent upon continued service as a director.
• Following the transaction, Mansukani beneficially owns 1,274,033 shares of Agilon Health, Inc., including restricted stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. A director increasing their stake in the company is generally a good sign, suggesting confidence in the company's future. However, it's a routine transaction related to compensation.

Positives

• The acquisition of shares by a director signals confidence in the company's future prospects.

Future Outlook

The restricted stock units vest on May 29, 2025, contingent on continued service as a director, indicating a commitment to the company's long-term success.

Industry Context

Director share acquisitions are generally viewed positively by the market as they align management's interests with those of shareholders. This Form 4 filing provides transparency into the insider transactions at Agilon Health.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates